An epigenetic clock can tell you your blood looks older or younger than your birth certificate. In large cohorts that gap tracks with mortality risk. In one person, on one test day, it is a far blurrier signal than the marketing suggests.
Longevity
Published by Astra, which offers some of the treatments discussed. Educational, not medical advice.
An epigenetic clock reads DNA methylation, a chemical tag added to specific sites on your DNA, at a defined set of positions in a blood or tissue sample. Certain sites gain or lose methylation in a fairly predictable way as people age, and a clock is a statistical model trained to turn that pattern into a single number: your estimated biological age.
That number is then compared to your chronological age, the one on your passport. If the clock's estimate comes out higher, the gap is often called accelerated aging. If it comes out lower, the marketing calls it reversal. Both framings imply more certainty than a single methylation readout can support.
The clock is not measuring damage directly. It is measuring a chemical correlate of damage, aggregated across a set of genomic sites, calibrated against data from other people. It is a proxy, and proxies inherit both the strengths and the noise of the process that built them.
The foundational result here is a study of DNA methylation age in blood from a large Scottish cohort, which found that the gap between methylation age and chronological age predicted all-cause mortality in later life, even after adjusting for chronological age itself.1 People whose blood looked epigenetically older than their years died sooner, on average, than people whose blood looked younger.
A subsequent meta-analysis pooled several methylation-based age measures across multiple large cohorts, most enrolling older adults of predominantly European ancestry, and again found that the methylation age gap predicted time to death.2 Pooling cohorts this way strengthens confidence that the association is real and not a quirk of one dataset, but it also means the result describes the populations that were studied. It says less about groups that were thinly represented in those cohorts, and it says nothing about causation.
Both of these are hazard ratios: a way of expressing that, across a group of people, having a higher methylation age was associated with a higher rate of death per unit time. A hazard ratio is a population-scale statement. It is not a prophecy about any one person's remaining years, and it does not identify which lifestyle change, if any, would move an individual's number or their actual risk.
Epigenetic age is not one number that applies uniformly to every organ. A study measuring methylation age directly in liver tissue found that obesity accelerates epigenetic aging of the liver specifically, a tissue-level effect distinct from whatever a blood draw would show.3 The liver, given its role in metabolism, is a plausible place for an obesity-linked signal to show up first and most strongly.
The same line of work looked at what happened after bariatric surgery, an intervention that produces large, often rapid changes in weight and metabolic markers. The liver's epigenetic age did not rapidly reverse.3 Weight came down. The tissue-level aging signal did not track it on a similarly fast timeline.
That is the detail worth sitting with before believing any story about a quick fix for biological age. A dramatic metabolic intervention, one far more aggressive than any supplement or peptide protocol, did not produce a dramatic reversal of this particular clock in this particular tissue. If bariatric surgery does not do it quickly, an interventions with far smaller physiological footprints should be expected to move the number by even less, if at all.
One of the more carefully done analyses in this space looked at how the epigenetic clock relates to diet, exercise, education, and other lifestyle factors across a large sample.4 It found associations in the expected direction: healthier behaviors and more education were linked to a younger-looking epigenetic age. Those associations were statistically real.
They were also modest. The study did not report large swings in methylation age attributable to lifestyle factors. This matters because a modest, real association is very different from the large, dramatic reversals implied by some consumer marketing. The honest reading of this evidence is that lifestyle plausibly nudges the number a bit, not that it rewrites it.
It is also worth noting what an association study like this cannot do. It cannot separate cause from consequence. People who exercise more and have more education also tend to differ in dozens of other ways, from occupational exposure to healthcare access to underlying health status, any of which could be doing some or all of the work.
A separate technical concern sits underneath all of this: the reliability of the clocks. Work examining test-retest consistency of epigenetic clock measurements found meaningful noise from one measurement to the next in the same person, enough that a single reading can misrepresent someone's underlying trajectory.5 That paper proposed computational methods to improve reliability precisely because the raw measurement has this limitation. If a person's own repeat blood draws can drift the number around, a single test result claiming a precise biological age should be read with real caution.
Finally, consider the one study in this set that is a genuine randomized controlled trial rather than an observational cohort. The CALERIE trial randomized healthy, non-obese adults to two years of caloric restriction versus normal diet and later analyzed the effect on DNA methylation measures of biological aging.6 This is about as close as human research gets to a controlled test of whether a real, sustained lifestyle intervention changes the clock.
The effect was partial.6 Caloric restriction, delivered under trial conditions with two years of sustained adherence, moved the methylation-based aging measure, but not comprehensively or across every clock examined. That is the most rigorous piece of evidence available on whether you can deliberately shift this number, and its answer is: somewhat, under demanding conditions, not dramatically.
Put the pieces together. In large cohorts, a wider gap between methylation age and chronological age tracks with higher mortality risk.12 That is a real, replicated, population-level association, and it is the reason these clocks are taken seriously as research tools rather than dismissed outright.
But an association between a marker and an outcome is not the same as evidence that moving the marker moves the outcome. The liver work shows a tissue-specific aging signal that did not budge quickly even after a major metabolic intervention.3 The lifestyle work shows real but modest links, not large modifiable swings.4 The reliability work shows the marker itself carries measurement noise.5 And the one true randomized trial in this space produced only a partial effect after two full years of sustained caloric restriction.6
None of that means the clocks are worthless. It means they are doing what a mirror does: showing you a reflection of something that is already true about your biology, built from patterns learned across other people's outcomes. Standing further from the mirror, or under better light, does not change your face. If you want to change what the mirror shows, you have to change the thing it is reflecting, and the honest evidence says that process is slow, only partly understood, and nowhere near as controllable as a single test result likes to imply.
A clock is a mirror. Repainting the mirror is not the same as changing the face.
Astra Editorial, reviewing the epigenetic aging literature
It means you belong to a group that, on average across large cohorts, had somewhat higher mortality risk.12 That is a population-level hazard ratio, not an individual forecast. It does not tell you your personal remaining lifespan.
The evidence does not support fast, large reversals. Lifestyle associations with the clock are real but modest,4 and even two years of randomized caloric restriction produced only a partial effect on methylation age.6 Bariatric surgery, a far more aggressive intervention, did not rapidly reverse liver epigenetic aging either.3
Epigenetic clocks have measurable test-retest noise. Research on this reliability limit found enough variation between repeat measurements that a single reading should not be treated as a precise, fixed number.5
No. Astra does not sell a product shown to lower a validated biological age measure. This article exists to explain the evidence honestly, not to sell a fix for it.
Astra does not sell anything shown to lower a biological age number. No supplement, peptide, or protocol in our catalog has been validated against a methylation clock in a controlled trial, and we are not going to imply otherwise to sell you something. What the evidence does support, cardiorespiratory fitness, resistance training, and sustained caloric moderation, is available to you without a prescription. Keep reading in the Astra Learn library, and we will update this piece if the evidence changes.
This guide is educational and is not medical advice. Compounded medications are not FDA-approved. Speak with a licensed physician about your own care.